12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, several healthcare stocks experienced significant movements. Cadrenal Therapeutics (CVKD), vTv Therapeutics (VTVT), Passage Bio (PASG), TC BioPharm (TCBP), Brainstorm Cell (BCLI), and Kazia Therapeutics (KZIA) were gainers, with increases ranging from 5.62% to 8.5%. On the losing side, Adicet Bio (ACET), Adagene (ADAG), Bone Biologics (BBLG), TransCode Therapeutics (RNAZ), Cabaletta Bio (CABA), and DocGo (DCGO) saw declines between 5.49% and 22.1%.
January 22, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adicet Bio's shares fell by 22.1% to $1.94, with a market cap of $83.7 million.
The sharp decline in ACET's stock price suggests negative market sentiment, which could lead to further short-term depreciation.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Adagene stock decreased by 13.34% to $2.6, with a market cap of $113.9 million.
The significant after-market drop for ADAG could indicate bearish investor sentiment, potentially leading to a continued downtrend in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Bone Biologics' shares declined by 6.9% to $3.51, with a market cap of $1.8 million.
BBLG's after-market decline could reflect a negative investor reaction, possibly leading to further short-term price drops.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
Cabaletta Bio's shares declined by 5.87% to $19.27, with a market cap of $825.7 million.
CABA's after-market drop could be a sign of investor concern, potentially leading to further short-term declines in the stock price.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
DocGo shares fell by 5.49% to $3.25, with a market cap of $337.7 million.
The after-market decline in DCGO's stock price indicates potential investor skepticism, which could lead to a short-term negative trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
NEGATIVE IMPACT
TransCode Therapeutics shares fell by 5.96% to $0.79.
The decrease in RNAZ's stock price after-market may suggest a bearish outlook, which could negatively impact the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Brainstorm Cell's stock increased by 5.76% to $0.31, with a market value of $15.1 million.
BCLI's after-market gain could reflect investor optimism, potentially leading to a short-term positive price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Cadrenal Therapeutics' shares rose by 8.5% to $1.15, with a market value of $14.9 million.
The significant after-market gain for CVKD suggests positive investor sentiment, which could lead to a short-term uptrend in the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Kazia Therapeutics' stock rose by 5.62% to $0.37, with a market value of $9.7 million.
The after-market increase for KZIA may be a sign of investor confidence, which could lead to a short-term positive price trend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
Passage Bio's stock went up by 6.94% to $0.97, with a market value of $53.1 million.
The positive movement for PASG after hours could suggest investor confidence, potentially leading to a short-term positive trend in the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
TC BioPharm shares rose by 6.08% to $2.44, with a market value of $1.6 million.
The increase in TCBP's share price after-market could indicate a bullish sentiment among investors, possibly leading to a short-term uptrend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90
POSITIVE IMPACT
vTv Therapeutics' shares increased by 6.98% to $9.95, with a market cap of $20.2 million.
The after-market rise in VTVT's stock price indicates a positive reaction that could carry into the next trading session, potentially leading to further gains.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 90